Total raised
$28.3M
Last: Series F 2021-01
Stage
Mature
Founded
2004
Headcount
50
HQ
Ness Ziona
Sector
Health Tech & Life Sciences
About
Amorphical is a pioneering biotechnology company that develops and manufactures unique natural-based medicines and dietary supplements with high bio-availability, aiming at the improvement of calcium absorption and management, in tandem with balancing the body's acidity level (pH) derived by various biomedical conditions. These features are critical for maintaining health, repairing bone deficiencies, treating severe diseases, and aiding the development and strengthening of the body.
Amorphical’s leading scientists succeeded in stabilizing and preserving a rare natural form of calcium used by blue crayfish to develop a unique nanometric substance called amorphous calcium carbonate, which helps improve people's health and quality of life.
Funding history · 5 rounds · $28.3M total
2021-01
Series F
$6.0M
2020-01
Series F
$1.0M
2016-05
Series E
$8.8M
2014-03
Series C
$8.0M
2010-03
Series A
$1.8M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & Substances
Target customers
Industrial ManufacturingDiscrete IndustriesAerospaceHealthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcarePatients
Business model
B2BB2B2C
Highlights
1 PatentsVerified
Tags
pharmaceuticalssupplementsbiotechnologynutritioninvestorsprivate-investorspharma-companiesnovel-ingredientshospitalswellnessosteoporosiscancerspace-tech